Quest Diagnostics Data License (CSELS) Cost Share
Past New Requirement Updated
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- Charla Jackson ckj5@cdc.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) is forecasting a new requirement contract for an annual data submission related to drug testing. Specifically, this opportunity involves a data license with Quest Diagnostics Incorporated, focusing on the Partnerships and Evaluation Branch (PEB) under contract number 75D30122C13345/200-2022-13345. The estimated contract award date is September 1, 2025, with the opportunity posted on December 10, 2025.
While specific award values are not disclosed, the contract appears to be a cost-share arrangement for data licensing and drug testing services. The point of contact for this opportunity is Charla Jackson from the National Center for Injury Prevention and Control (NCIPC), who can be reached at ckj5@cdc.gov. No set-aside is specified for this contract, suggesting it is open to standard competitive bidding, and the administrative code CPNED indicates this is an Option 3 procurement.
Forecast text
Annual Data Submission - Drug Test - 75D30122C13345/200-2022-13345 - Option 3, Admin Code CPNED - Partnerships and Evaluation Branch (PEB). Quest Diagnostics Incorporated
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast